You are here

The Progress Report Progress never stops. Stay informed with the latest news on breast cancer research, treatment, and prevention.


AACR 2017 x

Research conferences are great opportunities to present new and emerging ideas, and the 2017 AACR Annual Meeting was no exception.

CDK4/6 inhibitors are a new class of drugs that have shown promise in the treatment of advanced ER- positive breast cancer. Cyclin dependent kinases (CDK) regulate the process of cell division, required for growth.